Health ❯ Healthcare ❯ Medical Research
Type 1 Diabetes Type 2 Diabetes GLP-1 Receptor Agonists Diabetic Retinopathy Insulin Therapy Smart Insulin Eye Diseases Dementia Diabetic Foot Ulcers Beta Cell Mass Measurement Maturity-Onset Diabetes of the Young (MODY) Alpha Cells Stem Cell Therapy Gastroesophageal Reflux Disease Space Medicine Optic Nerve Disorders Medication Wound Healing Type 2 Diabetes Mellitus Type 1 Diabetes Prevention Stent Complications Pancreas Transplantation Patient Care Retinal Degeneration Continuous Glucose Monitoring Research Ethics Clinical Trials American Diabetes Association Freedom of Expression Ethics in Research GLP-1 Drugs Bone Health
Want to see what podcasts are saying about this topic? Search across 145K+ podcasts. Explore Radar
Researchers published the analysis on July 1, 2026 and say randomized trials are needed to test whether GLP‑1 receptor agonists causally reduce mortality, amputations and hospital care for high‑risk patients
